CCM
AMED

Camber Capital Management’s Amedisys AMED Stock Holding History

Camber Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-800,000
Closed -$9.3M – 35
2013
Q2 		$9.3M Buy
+800,000
New +$9.16M 0.96% 30

Other funds holding AMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCA
KKR Credit Advisors San Francisco, California $796M AUM
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Camber Capital Management's AMED Position: Q3 2013 in Review

Camber Capital Management sold out of Amedisys (AMED) in Q3 2013, closing a stake of 800,000 shares — an estimated $9.3M sold.

Camber Capital Management first reported a position in AMED in Q2 2013 and held it in 1 quarter. The position peaked at $9.3M in Q2 2013. 130 funds tracked by Wall St. Rank hold AMED as of Q3 2013.

  • Camber Capital Management reported no remaining Amedisys position as of Q3 2013 after selling out during the quarter.
  • Camber Capital Management sold 800,000 Amedisys shares in Q3 2013, an estimated $9.3M.
  • Camber Capital Management first reported a position in Amedisys in Q2 2013 and held it in 1 quarter.
  • Camber Capital Management's Amedisys position peaked at $9.3M in Q2 2013.
  • 130 funds tracked by Wall St. Rank held Amedisys as of Q3 2013.

Based on Camber Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.